Related Experiment Videos
Streptoccocus pyogenes: a forgotten cause of severe community-acquired pneumonia
1Intensive Care Unit, Wellington Hospital, New Zealand.
Abstract:
We report a case of severe community-acquired pneumonia caused by Streptococcus pyogenes (Lancefield Group A streptoccocus) that was complicated by a streptococcal toxic shock syndrome. Although this micro-organism is an uncommon cause of community-acquired pneumonia, previously well individuals may be infected and the clinical course may be fulminant. A household contact was the likely point of infection. Invasive group A streptococcal disease continues to remain an important cause of morbidity and mortality in the community and therefore will continue to be encountered by intensive care physicians. Treatment of Group A streptococcal infection remains penicillin; however, clindamycin should be added in severe infection.
Insights
Severe pneumonia caused by Streptococcus pyogenes (Group A strep) can lead to toxic shock syndrome. This rare but serious infection requires prompt intensive care and often combination antibiotic therapy.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality.
- Streptococcus pyogenes (Group A Streptococcus) is an uncommon but potentially severe cause of CAP.
- Invasive Group A Streptococcal (iGAS) disease presents a continuous public health challenge.
Observation:
- A previously healthy individual developed severe CAP due to Streptococcus pyogenes.
- The pneumonia was complicated by streptococcal toxic shock syndrome (STSS).
- A household contact was identified as the likely source of infection.
Findings:
- Streptococcus pyogenes can cause fulminant pneumonia and STSS in well individuals.
- Invasive Group A Streptococcal disease remains a critical concern for intensive care physicians.
- Penicillin is the primary treatment, with clindamycin recommended for severe infections.
Implications:
- Highlights the importance of considering Streptococcus pyogenes in severe CAP, even in previously healthy patients.
- Underscores the need for vigilance regarding invasive Group A Streptococcal infections in the community.
- Emphasizes the role of combination antibiotic therapy (penicillin plus clindamycin) in managing severe cases.